Neeraj Agarwal Highlights Promising T-Cell Engager Data in Prostate Cancer at ASCO 2025

Neeraj Agarwal, Postdoctoral fellow at City of Hope, posted on X:

“Just in from ASCO25.

Finally a T-cell engager in prostate cancer mCRPC with minimal CRS syndrome (only grade 1, all outpatient dosing) and promising efficacy.

Congrats Mark Stein and team Journal of Clinical Oncology.”